The pathology and treatment of metastatic disease of the femur

E. T. Habermann, R. Sachs, R. E. Stern, David M. Hirsh, W. J. Anderson

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Two hundred eighty-three pathologic fractures and 23 impending fractures of the hip and femur were analyzed and compared after surgical treatment. One hundred ninety-six fractures were treated by internal fixation or prosthetic replacement and the adjunctive use of methylmethacrylate, and 110 were treated by surgery without the use of methylmethacrylate. Pain relief, ambulatory activities and survival rates were all enhanced in the methylmethacrylate group. The six failures of fixation in the nonacrylic group might have been prevented by the use of bone cement. Breast carcinoma was the most common metastasis, comprising 56% of the series. Kidney metastases, when treated aggressively, showed many long-term survivors. Lung metastases gave the worst prognoses. The overall series survival rates were 59% at six months and 48% at 12 months. The incidence of complications including infection were not related to the use of methylmethacrylate or preoperative radiation. Although many authors have reported the advantages of methylmethacrylate in stabilization of pathological fractures, none have compared the results by analyzing pain relief, ambulatory ability and survival times in those treated with and without bone cement. This study appears to clearly indicate that methylmethacrylate enhances the stability of the pathological fracture and contributes to achieving the goals of treatment in these severely compromised patients.

Original languageEnglish (US)
Pages (from-to)70-82
Number of pages13
JournalClinical Orthopaedics and Related Research
VolumeNo. 169
StatePublished - 1982
Externally publishedYes

Fingerprint

Methylmethacrylate
Femur
Pathology
Spontaneous Fractures
Bone Cements
Neoplasm Metastasis
Therapeutics
Survival Rate
Pain
Aptitude
Hip Fractures
Survivors
Radiation
Breast Neoplasms
Kidney
Lung
Survival
Incidence
Infection

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Habermann, E. T., Sachs, R., Stern, R. E., Hirsh, D. M., & Anderson, W. J. (1982). The pathology and treatment of metastatic disease of the femur. Clinical Orthopaedics and Related Research, No. 169, 70-82.

The pathology and treatment of metastatic disease of the femur. / Habermann, E. T.; Sachs, R.; Stern, R. E.; Hirsh, David M.; Anderson, W. J.

In: Clinical Orthopaedics and Related Research, Vol. No. 169, 1982, p. 70-82.

Research output: Contribution to journalArticle

Habermann, ET, Sachs, R, Stern, RE, Hirsh, DM & Anderson, WJ 1982, 'The pathology and treatment of metastatic disease of the femur', Clinical Orthopaedics and Related Research, vol. No. 169, pp. 70-82.
Habermann, E. T. ; Sachs, R. ; Stern, R. E. ; Hirsh, David M. ; Anderson, W. J. / The pathology and treatment of metastatic disease of the femur. In: Clinical Orthopaedics and Related Research. 1982 ; Vol. No. 169. pp. 70-82.
@article{111d973ffb454f62bc70081128e32f21,
title = "The pathology and treatment of metastatic disease of the femur",
abstract = "Two hundred eighty-three pathologic fractures and 23 impending fractures of the hip and femur were analyzed and compared after surgical treatment. One hundred ninety-six fractures were treated by internal fixation or prosthetic replacement and the adjunctive use of methylmethacrylate, and 110 were treated by surgery without the use of methylmethacrylate. Pain relief, ambulatory activities and survival rates were all enhanced in the methylmethacrylate group. The six failures of fixation in the nonacrylic group might have been prevented by the use of bone cement. Breast carcinoma was the most common metastasis, comprising 56{\%} of the series. Kidney metastases, when treated aggressively, showed many long-term survivors. Lung metastases gave the worst prognoses. The overall series survival rates were 59{\%} at six months and 48{\%} at 12 months. The incidence of complications including infection were not related to the use of methylmethacrylate or preoperative radiation. Although many authors have reported the advantages of methylmethacrylate in stabilization of pathological fractures, none have compared the results by analyzing pain relief, ambulatory ability and survival times in those treated with and without bone cement. This study appears to clearly indicate that methylmethacrylate enhances the stability of the pathological fracture and contributes to achieving the goals of treatment in these severely compromised patients.",
author = "Habermann, {E. T.} and R. Sachs and Stern, {R. E.} and Hirsh, {David M.} and Anderson, {W. J.}",
year = "1982",
language = "English (US)",
volume = "No. 169",
pages = "70--82",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",

}

TY - JOUR

T1 - The pathology and treatment of metastatic disease of the femur

AU - Habermann, E. T.

AU - Sachs, R.

AU - Stern, R. E.

AU - Hirsh, David M.

AU - Anderson, W. J.

PY - 1982

Y1 - 1982

N2 - Two hundred eighty-three pathologic fractures and 23 impending fractures of the hip and femur were analyzed and compared after surgical treatment. One hundred ninety-six fractures were treated by internal fixation or prosthetic replacement and the adjunctive use of methylmethacrylate, and 110 were treated by surgery without the use of methylmethacrylate. Pain relief, ambulatory activities and survival rates were all enhanced in the methylmethacrylate group. The six failures of fixation in the nonacrylic group might have been prevented by the use of bone cement. Breast carcinoma was the most common metastasis, comprising 56% of the series. Kidney metastases, when treated aggressively, showed many long-term survivors. Lung metastases gave the worst prognoses. The overall series survival rates were 59% at six months and 48% at 12 months. The incidence of complications including infection were not related to the use of methylmethacrylate or preoperative radiation. Although many authors have reported the advantages of methylmethacrylate in stabilization of pathological fractures, none have compared the results by analyzing pain relief, ambulatory ability and survival times in those treated with and without bone cement. This study appears to clearly indicate that methylmethacrylate enhances the stability of the pathological fracture and contributes to achieving the goals of treatment in these severely compromised patients.

AB - Two hundred eighty-three pathologic fractures and 23 impending fractures of the hip and femur were analyzed and compared after surgical treatment. One hundred ninety-six fractures were treated by internal fixation or prosthetic replacement and the adjunctive use of methylmethacrylate, and 110 were treated by surgery without the use of methylmethacrylate. Pain relief, ambulatory activities and survival rates were all enhanced in the methylmethacrylate group. The six failures of fixation in the nonacrylic group might have been prevented by the use of bone cement. Breast carcinoma was the most common metastasis, comprising 56% of the series. Kidney metastases, when treated aggressively, showed many long-term survivors. Lung metastases gave the worst prognoses. The overall series survival rates were 59% at six months and 48% at 12 months. The incidence of complications including infection were not related to the use of methylmethacrylate or preoperative radiation. Although many authors have reported the advantages of methylmethacrylate in stabilization of pathological fractures, none have compared the results by analyzing pain relief, ambulatory ability and survival times in those treated with and without bone cement. This study appears to clearly indicate that methylmethacrylate enhances the stability of the pathological fracture and contributes to achieving the goals of treatment in these severely compromised patients.

UR - http://www.scopus.com/inward/record.url?scp=0019985487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019985487&partnerID=8YFLogxK

M3 - Article

C2 - 6179683

AN - SCOPUS:0019985487

VL - No. 169

SP - 70

EP - 82

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

ER -